Timothy Law: GLP-1 Drugs Changed the Paradigm in Weight Loss | AHIP 2024.

GLUCAGON-like peptide-1 agonists; WEIGHT loss; HEALTH insurance; CONFERENCES & conventions; ANTIOBESITY agents

An interview with Timothy Law, DO, MBA, chief medical officer of Highmark, delves into the transformative impact of GLP-1 agonist drugs such as Wegovy and Zepbound on weight loss strategies. Topics include the drugs' role in healthcare, the need for balanced expectations regarding their effectiveness, and the integration of lifestyle management in treatment approaches.